Garlock Sealing Technologies

Garlock Sealing Technologies History of Asbestos Use

Garlock Sealing Technologies started using asbestos in its products as early as 1907. These products were used widely in engines, boilers and other machinery with valves that needed to be leakproof.

Olin J. Garlock founded Garlock Sealing Technologies in 1887 in Palmyra, New York. Garlock originally built his business model on manufacturing sealing rods for industrial steam engines. Over time, the company expanded its product offering to include gaskets, pipe packing and tape.

Garlock products were heavily used during World War II. Many Navy shipyards used gaskets, packing and sealing materials to insulate pipes and other machinery aboard ships and to prevent leaks.

Garlock continually expanded its product lines following the war. As its sales skyrocketed, the company eventually became the largest producer of packing materials in the United States. Throughout this time, Garlock continued to use asbestos in various products it manufactured.

In 1976, Garlock was acquired by Coltec Industries, an industrial manufacturer. After the acquisition, Garlock continued to use asbestos for some time. The company reportedly halted its asbestos use in the 1980s.

In 1987, Garlock acquired another company with a long history of asbestos use, Anchor Packing Company. The acquisition came just three years after Anchor Packing Company had stopped manufacturing asbestos products of its own.

Anchor Packing Company closed its doors in 1993, and as its owner, Garlock took over its liabilities. Garlock and Anchor Packing Company have faced hundreds of thousands of asbestos-related lawsuits because of their asbestos use.

In 2003, Garlock became a wholly-owned subsidiary of Enpro Industries and filed for bankruptcy in 2010. A trust fund was established in 2017 to handle Garlock and Anchor Packing Company’s asbestos claims. Garlock Sealing Technologies still operates today under the Enpro umbrella.

GST Settlement Facility Asbestos Trust Fund

Garlock Sealing Technologies filed for Chapter 11 bankruptcy in June 2010. Garlock’s bankruptcy reorganization plan was officially approved on May 20, 2016. The company established the asbestos trust fund to resolve its asbestos-related liabilities.

The GST Settlement Facility trust fund began accepting asbestos claims in September 2018 for individuals harmed by asbestos-containing products manufactured, sold or distributed by Garlock Sealing Technologies LLC and its subsidiaries or acquired companies, including Anchor Packing Company, as well as certain products formerly associated with Coltec Industries. The trust was initially funded with $480 million.

People who develop asbestos-related illnesses after exposure to Garlock or Coltec products may be eligible to file a claim with the trust. Claims are then processed and may result in compensation. The maximum compensation amounts for mesothelioma victims were increased in 2025.

Most Recent Information From the GST Settlement Facility Asbestos Trust

The trust’s year-end 2024 report revealed, as of December 31, 2024:

• Approximately 2,700 GST Settlement Facility asbestos trust claims were paid.
• Approximately 3,110 personal injury claims were received by the trust.
• Over $31.35 million was paid to asbestos victims by the GST Settlement Facility asbestos trust.
• Over $1.124 million was reported in settled but unpaid claims.
• Approximately $387.33 million in total assets remain in the trust.

Current GST Settlement Facility Asbestos Trust Payment Percentage

The GST Settlement Facility Asbestos Trust does not use traditional payment percentage. Instead, claims are evaluated and paid pursuant to the Claims Resolution Procedures (CRP). The Trust does not assign fixed Scheduled or Average Values; rather, each claim is assigned a Maximum Settlement Value based on the claimant’s disease level and exposure, as dictated by a specified Occupation Classification Contact Group chart. This value is then adjusted based on additional factors set forth in the CRP.

A Garlock mesothelioma claim that meets all medical and exposure requirements may qualify for the Maximum Settlement Value of up to $342,900. Actual compensation will vary depending on the specific circumstances of the claim.

Determining Review Process When Filing a Garlock Sealing Technologies Asbestos Trust Claim

An experienced asbestos lawyer will evaluate the claimant’s case and select the appropriate review process when submitting a GST Settlement Facility asbestos claim. The Trust offers only Expedited Claim Review and Extraordinary Claim Review. Claim values are determined based on the injured party’s individual characteristics, including disease, occupation, industry, duration of exposure to Garlock/Coltec products, age, life status, dependents, economic loss and jurisdiction. If the exposure and medical criteria are met, the claim is eligible to receive the Matrix amount.

• Expedited Review: A streamlined process in which the Trust evaluates claims using a formula based on the injured party’s disease, occupation, industry, duration of exposure and personal factors. The Trust assigns the claim to an occupation classification contact group and applies an “IP Factor Index” to a maximum settlement value to calculate a Standardized Matrix Amount settlement offer.
• Extraordinary Claim Review: Requires a malignant diagnosis with predominant exposure to Garlock/Coltec products and minimal exposure to other asbestos products. The Trust calculates the standard Matrix Amount and multiples it by 5 to determine the Maximum Extraordinary Settlement. The Trustee then sets a final settlement percentage based on overall exposure and other claims, and the decision is final and non-reviewable.

The trust is currently accepting Garlock asbestos claims to compensate eligible victims. If you or a loved one were exposed to Garlock asbestos products and believe you are entitled to compensation, learn how a mesothelioma lawyer can help.

Garlock Sealing Technologies Asbestos Products

Garlock manufactured many different types of products. Many of these products contained asbestos. Garlock’s asbestos products included gaskets, packing, mechanical seals and a limited run of asbestos cloths and textiles.

Some of Garlock’s products contained asbestos as early as 1907. The company used asbestos to increase durability and resistance to fire and heat. The products were sold under various brand names, such as Garlock, Blue-Gard, Gylon and Flexseal.

Garlock Sealing Technologies and Occupational Exposure

Because of Garlock’s use of asbestos, many of the company’s employees risked exposure. Garlock employees involved in manufacturing these products often had a higher risk of asbestos exposure. Any amount of asbestos exposure may lead to an asbestos-related disease like mesothelioma cancer.

Many industries used these products, including:

• Chemical processing
• Construction
• Papermaking
• Power generation
• Semiconductor manufacturing
• Waste treatment

Garlock’s asbestos-containing products were most commonly used in construction applications, aboard naval ships and on trains. Naval shipyard workers, veterans and construction workers were among the most likely to be exposed to asbestos on the job from Garlock products.

Garlock’s gaskets were its most prominent product, and they were made with asbestos. The gaskets could release asbestos fibers into the air when damaged or removed. Workers who cut, hammered or removed gaskets made by Garlock or maintained nearby products may have been exposed.

To remove a gasket, workers had to pry the gasket off using implements like putty knives. They would then brush away any gasket residue and remove any insulation, which could also contain asbestos, around the joint or valve. The entire process released asbestos fibers into the air, exposing workers and others in the area.

Asbestos Litigation Against Garlock Sealing Technologies

Garlock Sealing Technologies faced thousands of lawsuits because of its asbestos-containing products and those of its subsidiary, Anchor Packing Company. In 2008 alone, Garlock reported $37 million in asbestos payments. By 2010, the company reportedly paid more than $1.4 billion in mesothelioma settlements and lawsuit verdicts from 900,000 asbestos claims.

One notable mesothelioma lawsuit involving Garlock products was decided in 2009. A Philadelphia jury awarded $17 million to the families of two deceased mesothelioma patients. The patients had worked around asbestos products for many years, including Crane Co. valves and Garlock gaskets. Evidence presented at trial revealed Garlock’s gaskets were made of up to 90% asbestos.

After many years of asbestos litigation costs in the millions, Garlock filed for bankruptcy in 2010. However, it would take until 2018 for the company’s asbestos bankruptcy trust fund to be open for claims.

In the meantime, Garlock continued to be named in lawsuits. For example, in 2012, a paper mill worker filed a lawsuit after being diagnosed with malignant pleural mesothelioma. He had worked as a boiler mechanic at a mill in Johnsonburg, Pennsylvania, where he was exposed to Garlock’s asbestos cement, gaskets and packing materials. The jury ruled in favor of the worker with a $12 million verdict. The case was settled for an unspecified amount following the verdict.